Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.
about
Rhabdomyolysis with concurrent atorvastatin and diltiazemDose of midazolam should be reduced during diltiazem and verapamil treatments.Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes.Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.Intravenous diltiazem and CYP3A-mediated metabolism.Exposure-response relationships and drug interactions of sirolimusHypertension in kidney transplant recipients.Effect of Multiple-Dose Diltiazem on the Pharmacokinetics of the Renin Inhibitor ACT-077825.Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis.The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients.The effect of oral verapamil therapy on antipyrine clearance.Altered diltiazem metabolism in the neonatal rabbit following intra-uterine chronic exposure to diltiazem.The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.Effect of administration route and length of exposure on pharmacokinetics and metabolism of diltiazem in dogs.Inhibitory effects of corticoids on reductive halothane dehalogenation.Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.Oral verapamil and calcium and vitamin D metabolism in rats: effect of dietary calcium.
P2860
Q28193807-DDB91306-C0AC-48E3-A010-9636EA332200Q34346089-89422CDC-AEDB-4209-8A25-4D9DC7CD9776Q34397793-AE38B732-7EE9-40D1-B0E0-7EF620B148C1Q35826861-338B516E-26E1-4E2A-BF1D-1EB1C112308AQ36055276-7C594D43-E584-4AC9-BCEE-665D0F3B4665Q37361711-1ACAA72A-D2C8-478A-98A9-EBDE959993C0Q37850471-5173778F-D44F-49D1-BCC8-EFF219C6E013Q39816378-F7531A1C-0F0E-41D8-ACCD-75A1245F88D8Q41775174-DBD29428-E2B1-40E1-82D8-C429DEE9BD95Q41970419-134112BE-8FD4-4356-A831-68B3EF1AB9F0Q42231825-F946D857-1954-43D4-9BCC-07DC06CAB373Q43682836-30B3059A-DEE9-422D-8BED-D82251CA691CQ43775593-2F7DDA38-B76C-43D5-A550-157611A8ECCBQ43854986-04AF3C93-048C-4C53-9CDD-4E92EBF1628DQ46290419-28722D9D-8793-4A49-8251-D760B63C7784Q46608474-752A941B-6181-4642-B47B-10F5A958D2EBQ54341910-98C3EB6F-0D5D-4D07-801E-56C3D3B22CB2
P2860
Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@en
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@nl
type
label
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@en
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@nl
prefLabel
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@en
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@nl
P1476
Inhibition of hepatic microsom ...... ckers diltiazem and verapamil.
@en
P2093
P304
P356
10.1016/0006-2952(85)90541-6
P407
P577
1985-07-01T00:00:00Z